Dialysis: NxStage Medical reports record sales, hits new Wall Street low

August 8, 2012 by MassDevice staff

NxStage Medical's shares hit a new 52-week low, despite the company's record sales and a forecast-beating 2nd quarter.

NxStage Medical logo

NxStage Medical (NSDQ:NXTM) notched a new low watermark for the year, despite reporting a strong 2nd quarter with records sales.

NXTM shares briefly hit $13.20 today, the lowest they've been in the last 52 weeks. Shares regained few cents by the early afternoon to trade at $13.34, still down 16% on the day.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp